ADC Therapeutics ADCT Cash Flow Statement (2019-2026)

NYSE ADCT
$1.60 +0.09 (+5.63%)
As of: Nov 11, 2026 · 3:59 PM EST
Reported Financials

ADC Therapeutics Quarterly Cash Flow Statement

Periods 30 quarters
Latest Sep 2026

ADC Therapeutics reported cash from operations of -$27.88M and free cash flow of -$27.88M for the quarter ended Sep 2026, up 5.9% year over year. This cash flow statement covers 30 quarters of results from Jun 2019 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income
-34.38M-16.66M-64.37M-50.61M-25.49M-59.37M-48.92M-46.73M-85.03M-46.61M-36.54M-43.97M-30.73M-38.60M-56.65M-40.97M-6.41M-32.97M-16.57M-25.30M
Depreciation and DepletionDep. & Depletion
0.34M0.26M0.26M0.25M0.29M0.26M0.27M0.32M0.34M0.33M0.33M0.34M0.34M0.34M0.36M
Depreciation, Depletion & Amortization
Amortization of IntangiblesAmort. of Intangibles
0.03M0.03M0.03M0.03M0.03M0.05M0.05M0.05M
Amortization of Deferred ChargesAmort. Deferred Charges
0.86M4.49M6.71M7.16M6.86M6.93M7.17M7.26M7.07M6.88M7.40M7.78M6.84M7.36M7.68M
Depreciation & Amortization (CF)Dep. & Amort.
0.34M0.26M0.26M0.25M0.29M0.26M0.27M0.32M0.34M0.33M0.33M0.34M0.34M0.34M0.36M
Share-based CompensationStock Comp.
13.46M13.40M13.82M14.57M7.54M8.07M1.12M2.08M2.22M0.16M1.99M2.81M1.62M2.42M1.81M2.00M0.67M2.44M4.55M4.09M
Deferred Taxes
-26.05M-3.86M-4.14M0.44M5.93M-0.07M-5.10M-0.58M42.85M
Cash from Discontinued OperationsCash from Discont. Ops
Gains from Equity InvestmentsGains Equity
-2.77M-2.50M-1.92M-2.13M-3.54M-1.36M-0.77M-1.41M-1.99M-0.69M-0.60M-0.26M
Gains from Investment SecuritiesGains Investment
18.61M15.86M14.46M-4.66M
Asset Writedowns and ImpairmentWritedown
-1.05M-0.36M2.30M0.77M-0.54M0.05M0.73M0.83M0.75M0.29M0.48M1.25M0.39M0.24M0.41M1.47M0.17M0.29M
Other non-cash itemsOther Non-Cash
0.51M0.24M0.09M12.20M19.49M0.66M1.23M1.02M-1.98M3.41M-1.78M-0.50M0.15M0.86M-0.71M-2.72M-14.40M1.22M
Non-cash ItemsNon-Cash Items
-54.13M-29.37M-55.76M13.67M0.38M-42.28M-37.51M-33.50M
Change in Working Capital
Change in ReceivablesChange Receivables
14.32M-3.47M-5.89M2.42M49.69M-48.90M-0.19M-2.70M4.00M-2.00M-0.32M1.26M-3.71M11.45M-5.58M-3.27M6.19M1.93M-3.01M0.38M
Change in InventoryChange Inventory
3.98M-0.36M-3.93M-1.86M15.80M0.35M2.05M3.48M-0.17M0.57M-0.52M0.88M2.80M0.31M0.71M0.52M0.85M-0.02M3.29M0.64M
Change in Account PayablesChange Payables
1.74M4.38M-3.41M-1.38M0.72M-3.66M2.98M-2.71M6.57M-1.25M-4.84M4.87M3.68M-2.46M-6.22M-1.29M0.93M-3.87M7.47M-6.36M
Change in Accrued ExpensesChange Accrued Exp.
-12.30M-3.29M-0.52M1.96M-3.54M-2.19M5.57M11.31M-20.63M12.04M-0.80M1.97M-3.18M3.82M-3.81M
Change in TaxesChange Taxes
4.08M2.69M3.19M-1.15M-2.87M0.59M0.61M0.49M
Change in Other Operating AssetsOther Assets Change
2.00M1.42M-0.94M5.17M6.02M-0.64M-4.49M-1.31M-1.05M0.70M0.45M1.37M-0.58M-3.86M-3.05M1.50M0.22M-2.01M-0.25M5.80M
Change in Other Operating LiabilitiesOther Liabilities Change
8.02M-10.67M9.88M5.47M-5.88M-0.32M2.71M2.23M1.05M-5.86M1.81M1.61M-6.45M1.47M1.61M1.23M-7.23M1.96M1.08M2.63M
Other Working Capital ChangesOther WC Changes
6.02M-1.07M4.86M-3.31M-11.90M0.06M7.20M3.55M2.10M-6.56M1.37M0.24M-5.87M5.33M4.66M-0.27M-7.45M3.96M1.33M-3.17M
Other Operating Activities (as filed)
0.02M0.02M0.02M0.27M1.64M2.80M2.37M2.70M1.86M4.38M3.25M3.44M2.63M2.05M1.93M2.47M2.35M1.99M1.50M1.94M
Cash from OperationsCash from Ops.
-61.63M-33.88M-53.01M2.20M-53.61M-15.39M-34.99M-36.67M-31.63M-44.10M-32.85M-25.04M-21.85M-56.33M-24.09M-29.63M-31.12M-29.71M-11.81M-27.88M
Investing Activities
Capital ExpendituresCapex
0.42M0.23M0.05M0.19M0.21M1.02M1.21M0.66M0.33M0.53M0.03M0.22M0.09M0.26M0.03M
Change in Property, Plant and EquipmentChange in PP&E
-0.42M-0.23M-0.05M-0.19M-0.21M-1.02M-1.21M-0.66M-0.33M-0.53M-0.03M-0.22M-0.09M-0.26M-0.03M
Change in IntangiblesChange Intangibless
0.11M0.89M0.76M0.06M0.01M0.02M0.00M
Other Investing Activities (as filed)Other investing (as filed)
-0.30M-0.33M0.12M
Cash from Investing ActivitiesCash from Investing
-0.83M-1.45M-0.69M-0.25M1.70M-1.02M-1.21M-0.66M-0.33M-0.53M-0.03M-0.22M-0.09M-0.26M0.66M-0.03M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
115.60M
Long-Term Debt RepaymentsLT Debt Repayment
-0.23M-0.26M-0.25M-0.25M119.06M-0.20M-0.26M-0.41M0.87M
Net Long-Term Debt Issued (Repaid)Net LT Debt
0.23M0.26M0.25M0.25M-3.46M0.20M0.26M0.41M-0.87M
Short-Term Debt issuancesST Debt Issuance
-117.27M
Net Short-Term Debt Issued (Repaid)Net ST Debt
-117.27M
Net Debt Issuances and RepaymentsNet Debt Issuance
0.23M0.26M0.25M0.25M-120.74M0.20M0.26M0.41M-0.87M
Change in Capital Stock
Common Stock IssuedStock Issued
0.26M6.19M-0.06M0.43M0.35M0.00M0.36M98.70M-0.88M0.04M0.27M94.03M-0.20M58.35M0.19M0.12M-0.61M
Shares Repurchased
Net Shares Issued and RepurchasedNet Shares Issued
0.26M6.19M-0.06M0.43M0.35M0.00M0.36M98.70M-0.88M0.04M0.27M94.03M-0.20M58.35M0.19M0.12M-0.61M
Net Equity Issued and RepurchasedNet Equity Issued
0.26M6.19M-0.06M0.43M0.35M0.00M0.36M98.70M-0.88M0.04M0.27M94.03M-0.20M58.35M0.19M0.12M-0.61M
Other financing activities (as filed)
-0.23M-0.26M-0.25M-0.25M-3.56M-0.20M-0.26M-0.41M0.87M-1.16M-0.25M-1.26M-0.77M-0.22M
Cash from Financing ActivitiesCash from Financing
-1.22M-0.26M-0.25M2.37M-2.75M0.43M73.10M0.35M0.00M0.36M98.70M-0.88M-1.12M0.27M93.78M-0.20M57.09M-0.58M-0.10M-2.11M
Additional items
Exchange Rate EffectFX Effect
0.03M-0.08M-0.15M-0.22M0.24M0.09M0.06M-0.12M0.15M-0.04M0.01M0.29M-0.34M0.16M0.16M0.01M-0.03M-0.01M0.01M0.08M
Change in Cash
-63.68M-35.59M-53.95M4.31M-54.66M-15.98M36.90M-36.99M-31.96M-44.27M65.82M-26.14M-23.06M-56.33M69.70M-29.83M26.63M-30.33M-11.91M-29.98M
Ending Cash Balance
466.54M430.87M376.78M380.86M326.44M310.55M347.51M310.41M278.60M234.29M300.12M274.27M250.87M194.70M264.56M234.74M261.34M231.01M219.11M189.20M
Free Cash FlowFCF
-62.05M-34.11M-53.06M2.00M-53.83M-16.41M-36.20M-37.33M-31.96M-44.63M-32.88M-25.26M-21.94M-56.60M-24.09M-29.63M-31.12M-29.74M-11.81M-27.88M
Net Cash FlowNCF
-63.68M-35.59M-53.95M4.31M-54.66M-15.98M36.90M-36.99M-31.96M-44.27M65.82M-26.14M-23.06M-56.33M69.70M-29.83M26.63M-30.33M-11.91M-29.98M
Interest Paid
1.81M1.84M1.72M3.36M3.25M3.71M3.81M3.91M3.96M3.90M3.97M4.07M3.76M3.59M3.62M3.66M3.59M3.40M3.44M3.49M
Income Taxes PaidTaxes Paid
0.05M8.81M2.57M2.09M0.30M-3.21M-1.85M

ADC Therapeutics Cash Flow Statement API

Pull ADC Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ADCT&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY